Skip to main content
Top

Journal of Inherited Metabolic Disease

Issue 6/2014

Content (17 Articles)

Original Article

Expanded newborn screening in New South Wales: missed cases

Jane Estrella, Bridget Wilcken, Kevin Carpenter, Kaustuv Bhattacharya, Michel Tchan, Veronica Wiley

Original Article

Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases

Sowmiya Moorthie, Louise Cameron, Gurdeep S. Sagoo, Jim R. Bonham, Hilary Burton

Original Article

A detailed analysis of methylmalonic acid kinetics during hemodialysis and after combined liver/kidney transplantation in a patient with mut 0 methylmalonic acidemia

Hilary J. Vernon, C. John Sperati, Joshua D. King, Andrea Poretti, Neil R. Miller, Jennifer L. Sloan, Andrew M. Cameron, Donna Myers, Charles P. Venditti, David Valle

Original Article

Functional studies of 18 heterologously expressed medium-chain acyl-CoA dehydrogenase (MCAD) variants

Kira-Lee Koster, Marga Sturm, Diran Herebian, Sander H. J. Smits, Ute Spiekerkoetter

Original Article

Effectiveness of enzyme replacement therapy in adults with late-onset Pompe disease: results from the NCS-LSD cohort study

L. J. Anderson, W. Henley, K. M. Wyatt, V. Nikolaou, S. Waldek, D. A. Hughes, R. H. Lachmann, S. Logan

Original Article

Long-term effectiveness of enzyme replacement therapy in adults with Gaucher disease: results from the NCS-LSD cohort study

L. J. Anderson, W. Henley, K. M. Wyatt, V. Nikolaou, D. A. Hughes, S. Waldek, S. Logan

Original Article

Long-term effectiveness of enzyme replacement therapy in children with Gaucher disease: results from the NCS-LSD cohort study

L. J. Anderson, W. Henley, K. M. Wyatt, V. Nikolaou, S. Waldek, D. A. Hughes, G. M. Pastores, S. Logan

Original Article

Long-term effectiveness of enzyme replacement therapy in Fabry disease: results from the NCS-LSD cohort study

L. J. Anderson, K. M. Wyatt, W. Henley, V. Nikolaou, S. Waldek, D. A. Hughes, G. M. Pastores, S. Logan

Open Access Original Article

Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study

Christian J. Hendriksz, Barbara Burton, Thomas R. Fleming, Paul Harmatz, Derralynn Hughes, Simon A. Jones, Shuan-Pei Lin, Eugen Mengel, Maurizio Scarpa, Vassili Valayannopoulos, Roberto Giugliani, Peter Slasor, Debra Lounsbury, Wolfgang Dummer

Original Article

Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy

L. van Dussen, E. J. Hendriks, J. E. M. Groener, R. G. Boot, C. E. M. Hollak, J. M. F. G. Aerts

Original Article

Evaluation of an imaging biomarker, Dixon quantitative chemical shift imaging, in Gaucher disease: lessons learned

L. van Dussen, E. M. Akkerman, C. E. M. Hollak, A. J. Nederveen, M. Maas

Original Article

Effective clearance of GL-3 in a human iPSC-derived cardiomyocyte model of Fabry disease

Jean-Michel Itier, Gwénaëlle Ret, Sandra Viale, Lindsay Sweet, Dinesh Bangari, Anne Caron, Françoise Le-Gall, Bernard Bénichou, John Leonard, Jean-François Deleuze, Cécile Orsini

Erratum

Erratum to: Clinical, biochemical and molecular analysis of 13 Japanese patients with β-ureidopropionase deficiency demonstrates high prevalence of the c.977G > A (p.R326Q) mutation

Yoko Nakajima, Judith Meijer, Doreen Dobritzsch, Tetsuya Ito, Rutger Meinsma, Nico G. G. M. Abeling, Jeroen Roelofsen, Lida Zoetekouw, Yoriko Watanabe, Kyoko Tashiro, Tomoko Lee, Yasuhiro Takeshima, Hiroshi Mitsubuchi, Akira Yoneyama, Kazuhide Ohta, Kaoru Eto, Kayoko Saito, Tomiko Kuhara, André B. P. van Kuilenburg

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.